首页|期刊导航|安徽医科大学学报|AMPK活化在红景天苷改善动脉粥样硬化小鼠模型内皮祖细胞功能中的作用

AMPK活化在红景天苷改善动脉粥样硬化小鼠模型内皮祖细胞功能中的作用OA

Salidroside exerts cytoprotective effects on bone endothelial progenitor cells via the AMPK pathway in atherosclerotic mouse model

中文摘要英文摘要

目的 探讨腺苷酸激活蛋白激酶(AMPK)活化在红景天苷(SAL)改善动脉粥样硬化(As)小鼠模型功能受损的内皮祖细胞(EPCs)生物活性中的作用.方法 通过高脂饮食喂养ApoE-/-小鼠建立As模型,观察SAL灌胃对主动脉斑块负荷和血清一氧化氮(NO)水平的影响;分离培养骨髓来源EPCs(BM-EPCs),观察SAL体内外干预后,EPCs增殖、迁移、血管生成能力的改变;使用AMPK慢病毒干扰载体(AMPK-sh-RNA)或AMPK抑制剂Compound C干预体外培养的As模型小鼠骨髓来源EPCs,观察AMPK在SAL调节EPCs生物活性中的作用.结果 SAL组小鼠血清NO水平较As组升高;SAL干预组主动脉根部斑块相比As组减少,脂核较小;As模型小鼠EPCs的迁移和血管生成数量较对照小鼠下降,SAL组EPCs迁移及体外血管生成数量较As组上升;体外试验显示经20、40和80 μmol/L的SAL孵育48 h后EPCs的增殖、迁移和血管生成能力提升,AMPK-sh-RNA感染抑制了20 μmol/L SAL改善EPCs生物活性的作用;Western blot结果显示Compound C抑制了SAL诱导的AMPK/Akt/eNOS活化.结论 红景天苷通过AMPK/Akt/eNOS信号通路上调EPCs的生物活性,改善As病理进程中的EPCs功能损伤.

Objective To investigate the effects of salidroside(SAL)on the impaired bioactivity of endothelial progenitor cells(EPCs)in atherosclerotic(As)mice and the potential mechanisms regarding AMP-activated pro-tein kinase(AMPK).Methods Atherosclerosis was induced in 8-week-old male ApoE-/-mice with high-fat diet.Intragastric administration of SAL was given to one mice group to investigate the effects of SAL on aortic plaque bur-den,plasma NO level,the migration and angiogenic capabilities of bone marrow-derived EPCs(BM-EPCs).The proliferation,migration and vasculogenic properties of EPCs isolated from As mice were investigated in vitro.AMPK-sh-RNA or the AMPK inhibitor Compound C was used to investigate the role of AMPK/Akt/eNOS pathway in the regulatory effects of SAL.Results Compared with As group,NO level was significantly elevated in SAL group.The sizes of atherosclerotic plaques at the aortic root were reduced with smaller lipid cores in SAL group compared with As group.Moreover,the migration and angiogenesis capacity of EPCs markedly decreased in As mice,while SAL treatment reversed these impairments.Incubation with SAL at concentrations of 20,40,and 80 μmol/L for 48 hours significantly promoted the proliferation,migration,and angiogenesis of EPCs.AMPK-sh-RNA transfection abrogated the 20 μmol/L SAL improvement in EPC biological activities.Western blot analysis further demonstrated that treatment with Compound C blocked the activation of AMPK/Akt/eNOS signaling pathway in-duced by SAL.Conclusion SAL upregulates the biological functions of EPCs through activating the AMPK/Akt/eNOS signaling pathway,thereby ameliorating EPC dysfunction during the pathological progression of atherosclero-sis.

贾方;王梦非;费思凡;徐加怡;俞天虹;朱琳;周敏

苏州大学附属第三医院心内科,常州 213003苏州大学附属第三医院心内科,常州 213003苏州大学附属第三医院心内科,常州 213003苏州大学附属第三医院心内科,常州 213003苏州大学附属第三医院心内科,常州 213003苏州大学附属第三医院心内科,常州 213003苏州大学附属第三医院心内科,常州 213003

医药卫生

红景天苷内皮祖细胞腺苷酸激活蛋白激酶动脉粥样硬化内皮型一氧化氮合酶AMPK/Akt/eNOS信号通路

salidrosideendothelial progenitor cellsAMP-activated protein kinaseatherosclerosiseNOSAMPK/Akt/eNOS pathway

《安徽医科大学学报》 2026 (4)

653-661,9

国家自然科学基金项目(编号:81300220)常州市卫健委重大科技项目(编号:ZD202212)常州市卫生健康人才国内外研修资助项目(编号:GN2023006)苏州工业园区东方华夏心血管健康研究院-天然调脂药物循证科研基金项目(编号:2023-CCA-NLD-431)常州市第四周期医学重点学科项目(编号:CZXK202202) National Natural Science Foundation of China(No.81300220)Major Science and Technology Program of Changzhou Health Commission(No.ZD202212)Domestic and International Training Support Pro-gram for Health Talent of Changzhou(No.GN2023006)Chinese Cardiovascular Association-Natural Lipid-lowering Drugs Fund(No.2023-CCA-NLD-431)Changzhou Key Medical Discipline Fund(No.CZXK202202)

10.19405/j.cnki.issn1000-1492.2026.04.009

评论